Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

Pamela S. Douglas, Triin Umbleja, Gerald S. Bloomfield, Carl J. Fichtenbaum, Markella V. Zanni, Edgar T. Overton, Kathleen V. Fitch, Emma M. Kileel, Judith A. Aberg, Judith Currier, Craig A. Sponseller, Kathleen Melbourne, Anchalee Avihingsanon, Flavio Bustorff, Vicente Estrada, Kiat Ruxrungtham, Maria Saumoy, Ann Marie Navar, Udo Hoffmann, Heather J. RibaudoSteven Grinspoon

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences